Gene · 429
Papers4,495
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,495
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phenotypic Landscape of Pulmonary Neuroendocrine Tumors: Subtyped by OTP/ASCL1 Expression Correlated with Histology, Hormones and Outcome. | Endocr Pathol | 2025 | 41196447 | PubTator, text mining | PubMed |
| Aminophosphonate-Derived Lipid Nanoparticles Enable Circular RNA Delivery for Functional Recovery after Spinal Cord Injury. | Mater Today (Kidlington) | 2025 | 41169607 | PubTator, text mining | PubMed |
| Bridging Knowledge Gaps in Small Cell Lung Cancer: Data, Challenges and Priorities. | Curr Oncol | 2025 | 41149456 | PubTator, text mining | PubMed |
| Expression of YAP1 delineates distinct subtypes of pulmonary large cell neuroendocrine carcinoma with divergent therapeutic implications. | Transl Lung Cancer Res | 2025 | 41132957 | PubTator, text mining | PubMed |
| Tumor Heterogeneity and Plasticity in Small Cell Lung Cancer. | Lung Cancer (Auckl) | 2025 | 41098578 | PubTator, text mining | PubMed |
| Emerging Therapeutic Strategies for Lung Cancer: The Role of Immunotherapy and HPV-Targeted Cancer Vaccines. | Vaccines (Basel) | 2025 | 41012160 | PubTator, text mining | PubMed |
| Integrative analysis of molecular mechanisms in prostate cancer via single-cell RNA sequencing and weighted gene co-expression network analysis. | Sci Rep | 2025 | 41006377 | PubTator, text mining | PubMed |
| Higher levels of host-cell DNA methylation markers ZNF582 and ASCL1 on anal smears are predictive for progression to anal cancer in patients with previous high-grade lesions. | EBioMedicine | 2025 | 40997682 | PubTator, text mining | PubMed |
| Basal cell of origin resolves neuroendocrine-tuft lineage plasticity in cancer. | Nature | 2025 | 40963028 | PubTator, text mining | PubMed |
| Learning the cellular origins across cancers using single-cell chromatin landscapes. | Nat Commun | 2025 | 40962882 | PubTator, text mining | PubMed |
| RBM39 degrader invigorates innate immunity to eradicate neuroblastoma despite cancer cell plasticity. | Nat Commun | 2025 | 40962798 | PubTator, text mining | PubMed |
| Molecular mechanisms and clinical insights in transformed small cell lung cancer: a narrative review. | Transl Lung Cancer Res | 2025 | 40948831 | PubTator, text mining | PubMed |
| Prognostic values and clinical significance of POU2F3 expression in neuroendocrine carcinomas: a meta-analysis with a focus on small cell lung cancer. | Ann Med | 2025 | 40931642 | PubTator, text mining | PubMed |
| Characterization of the extrinsic and intrinsic signatures and therapeutic vulnerability of small cell lung cancers. | Signal Transduct Target Ther | 2025 | 40925909 | PubTator, text mining | PubMed |
| Seizure-Related Homolog Protein 6 (SEZ6): Biology and Therapeutic Target in Neuroendocrine Carcinomas. | Clin Cancer Res | 2025 | 40911432 | PubTator, text mining | PubMed |
Comprehensive Analysis of Neurogenic Differentiation Factor 1 (NEUROD1), Achaete-Scute Homolog 1 (ASCL1), POU Class 2 Homeobox 3 (POU2F3), and Yes-Associated Protein 1 (YAP1) Expression Signatures Reveals Unique Large-Cell Neuroendocrine Carcinoma (LCNEC) Subgroups With Potential Therapeutic Implications. | Lab Invest | 2025 | 40902984 | PubTator, text mining | PubMed |
| Deep learning-based histomorphological subtyping and risk stratification of small cell lung cancer from hematoxylin and eosin-stained whole slide images. | Genome Med | 2025 | 40898302 | PubTator, text mining | PubMed |
| Nano-Biosensors for mRNA-Based Cell Sorting Using Intracellular Markers at the Early Stage of Cell Reprogramming. | Adv Funct Mater | 2025 | 40895409 | PubTator, text mining | PubMed |
| Molecular Characteristics, Heterogeneity, Plasticity, and Cell of Origin of Neuroendocrine Bladder Cancer. | Cancer Heterog Plast | 2025 | 40893664 | PubTator, text mining | PubMed |
| Lineage-specific transcription factor landscape of thymic neuroendocrine tumors. | Lung Cancer | 2025 | 40884897 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/429/papers?page=9